Status:

WITHDRAWN

Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection

Lead Sponsor:

J Ints Bio

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Indication : Treatment of Subject with COVID-19 infection Phase : Phase I Duration of Study : 12 day Sample size : at least 15 subjects Methodology : Classical 3+3 design Investigational Product : MPT...

Eligibility Criteria

Inclusion

  • Subjects must meet all inclusion criteria as listed below:
  • Age ≥18 years at time of signing Informed Consent Form
  • Laboratory (quantitative Polymerase Chain Reaction, qPCR) confirmed infection with 2019-nCoV.
  • Lung involvement confirmed with chest imaging
  • Hospitalized with a SaO2/SPO2≤94% on room air or PaO2/FiO2 ratio \<300mgHg
  • ≤7 days since illness onset
  • Must agree not to enroll in another study of an investigational agent prior to completion of Day 12 of study.

Exclusion

  • Physician makes a decision that trial involvement is not in patients' best interest, or any condition that does not allow the protocol to be followed safely.
  • Severe liver disease (e.g. Child Pugh score ≥ C, AST\>5 times upper limit)
  • Pregnant or breastfeeding, or positive pregnancy test in a pre-dose examination
  • Patients with known severe renal impairment (estimated glomerular filtration rate ≤30 mL/min/1.73 m2) or receiving continuous renal replacement therapy, hemodialysis, peritoneal dialysis
  • Will be transferred to another hospital which is not the study site within 72 hours.
  • Receipt of any experimental treatment for 2019-nCoV (off-label, compassionate use, or trial related) within the 30 days prior to the time of the screening evaluation.

Key Trial Info

Start Date :

December 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04526717

Start Date

December 1 2021

End Date

December 1 2022

Last Update

June 11 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection | DecenTrialz